Dr. Adebayo (Bayo) Laniyonu has over 24 years of experience with the US Food and Drug Administration (FDA).

Prior to joining Anavex, Dr. Laniyonu served as a Supervisory Pharmacologist/Toxicologist at the FDA Center for Drug Evaluation and Research (CDER). He has reviewed hundreds of NDAs, BLAs (including first-in-class), sNDAs, ANDAs, and INDs and provided high-impact regulatory and strategic recommendations to the Sponsors of these products. He organized, chaired, and presented at FDA workshops and scientific sessions of professional societies where he presented on the FDA’s current thinking on regulatory issues and at FDA Advisory Committee meetings. His review and Supervisory experience span several therapeutic areas, including Rare Diseases and Medical Genetics, hematology, Medical Imaging, Radiation Medicine, and Medical countermeasures products. Dr. Laniyonu played a pivotal role in developing several FDA regulatory guidance documents.

Dr. Laniyonu holds a PhD in Pharmacology from the University of Glasgow, UK, where he was a Commonwealth Scholar. He was also a Canadian Cystic Fibrosis Post-Doctoral Fellow. Dr. Laniyonu was a recipient of many FDA distinguished awards, including the Department of Health and Human Services Secretary’s Award for Distinguished Service, FDA Award of Merit, FDA Outstanding Service Award, FDA Group Recognition Award, CDER Excellence in Communication Award, CDER Excellence in Mentoring Award.